According to BlockBeats, shares of Helius Medical Technologies (NASDAQ: HSDT) surged by 270% in pre-market trading following the company's announcement of a strategic transformation into a SOL treasury firm. The previous trading session closed with the company's stock priced at $7.56, and its market capitalization was approximately $8.14 million.
Helius has revealed a significant shift in its business strategy, backed by over $500 million in private investment. This transformation is led by Pantera Capital and Summer Capital through a PIPE (Private Investment in Public Equity) deal, which has been oversubscribed. The investment includes the sale of common stock at $6.881 per share and warrants priced at $10.134 each. If all warrants are exercised, the total fundraising could exceed $1.25 billion.
